Eye Program

Mission

The Eye Program at the Cedars-Sinai Regenerative Medicine Institute is dedicated to building a solid translational program in eye research based on innovative studies of common diseases including diabetes, corneal dystrophy keratoconus, limbal stem cell deficiency and retinal degenerations.

Our mission is to combine advances in gene therapy, global genetics and epigenetics, and stem cell research to identify pathological molecular mechanisms that can lead to new advanced therapies for specific eye diseases.

Focus

Transplanted human progenitor cells (red) survive in the retina to improve eyesight in animal models of retinitis pigmentosa, a form of retinal degeneration.

Faculty

Alexander Ljubimov, PhD
Shaomei Wang, MD, PhD
Yaron S. Rabinowitz, MD
Mehrnoosh Ghiam, PhD
Yelena Bykhovskaya, PhD
Collaborative Research

Have Questions or Need Help?

Contact us if you have questions, or wish to learn more about the Board of Governors Regenerative Medicine Institute.

Board of Governors Regenerative Medicine Institute
Pavilion, Eighth Floor
8700 Beverly Blvd.
Los Angeles, CA 90048

Fax: 310-248-8066